NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by Akers
Biosciences, Inc. (NASDAQ: AKER) and its board of directors
concerning the proposed merger of the company with MyMD
Pharmaceuticals, Inc. Akers Biosciences stockholders will own 20%
of the combined company. The transaction is expected to close in
the first half of 2021.
If you are a stockholder of Akers Biosciences, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/aker/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-akers-biosciences-inc-301172322.html
SOURCE Rowley Law PLLC